Please use this identifier to cite or link to this item: https://doi.org/10.1177/0269881104042632
DC FieldValue
dc.titlePharmacokinetic interactions of drugs with St John's wort
dc.contributor.authorZhou, S.
dc.contributor.authorChan, E.
dc.contributor.authorPan, S.-Q.
dc.contributor.authorHuang, M.
dc.contributor.authorLee, E.J.D.
dc.date.accessioned2014-05-19T02:57:25Z
dc.date.available2014-05-19T02:57:25Z
dc.date.issued2004-06
dc.identifier.citationZhou, S., Chan, E., Pan, S.-Q., Huang, M., Lee, E.J.D. (2004-06). Pharmacokinetic interactions of drugs with St John's wort. Journal of Psychopharmacology 18 (2) : 262-276. ScholarBank@NUS Repository. https://doi.org/10.1177/0269881104042632
dc.identifier.issn02698811
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/53350
dc.description.abstractThere is a worldwide increasing use of herbs which are often administered in combination with therapeutic drugs, raising the potential for herb-drug interactions. St John's wort (Hypericum perforatum) is one of the most commonly used herbal antidepressants. A literature search was performed using Medline (via Pubmed), Biological Abstracts, Cochrane Library, AMED, PsycINFO and Embase (all from their inception to September 2003) to identify known drug interaction with St John's wort. The available data indicate that St John's wort is a potent inducer of CYP 3A4 and P-glycoprotein (PgP), although it may inhibit or induce other CYPs, depending on the dose, route and duration of administration. Data from human studies and case reports indicate that St John's wort decreased the blood concentrations of amitriptyline, cyclosporine, digoxin, fexofenadine, indinavir, methadone, midazolam, nevirapine, phenprocoumon, simvastatin, tacrolimus, theophylline and warfarin, whereas it did not alter the pharmacokinetics of carbamazepine, dextromethorphan, mycophenolic acid and pravastatin. St John's wort decreased the plasma concentration of the active metabolite SN-38 in cancer patients receiving irinotecan treatment. St John's wort did not alter the pharmacokinetics of tolbutamide, but increased the incidence of hypoglycaemia. Several cases have been reported that St John's wort decreased cyclosporine blood concentration leading to organ rejection. St John's wort caused breakthrough bleeding and unplanned pregnancies when used concomitantly with oral contraceptives. It also caused serotonin syndrome when coadministered with selective serotonin-reuptake inhibitors (e.g. sertaline and paroxetine). Both pharmacokinetic and pharmacodynamic components may play a role in these interactions. Because the potential interaction of St John's wort with other drugs is a major safety concern, additional systematic research on herb-drug interactions and appropriate regulation in herbal safety and efficacy is needed.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1177/0269881104042632
dc.sourceScopus
dc.subjectCytochrome P450
dc.subjectDrug interactions P-glycoprotein
dc.subjectSt John's wort
dc.typeReview
dc.contributor.departmentBIOLOGICAL SCIENCES
dc.contributor.departmentPHARMACY
dc.description.doi10.1177/0269881104042632
dc.description.sourcetitleJournal of Psychopharmacology
dc.description.volume18
dc.description.issue2
dc.description.page262-276
dc.description.codenJOPSE
dc.identifier.isiut000222649000018
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

175
checked on Jul 13, 2019

WEB OF SCIENCETM
Citations

140
checked on Jul 13, 2019

Page view(s)

81
checked on Jun 22, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.